TransMedics Group, Inc.

NASDAQ:TMDX

155.96 (USD) • At close September 18, 2024
Bedrijfsnaam TransMedics Group, Inc.
Symbool TMDX
Munteenheid USD
Prijs 155.96
Beurswaarde 5,202,732,024
Dividendpercentage 0%
52-weken bereik 36.42 - 177.37
Industrie Medical Devices
Sector Healthcare
CEO Dr. Waleed H. Hassanein M.D.
Website https://www.transmedics.com

An error occurred while fetching data.

Over TransMedics Group, Inc.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic

Vergelijkbare Aandelen

Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc.

KYMR

46.44 USD

Health Catalyst, Inc. logo

Health Catalyst, Inc.

HCAT

8.74 USD

AngioDynamics, Inc. logo

AngioDynamics, Inc.

ANGO

7.6 USD

Alphatec Holdings, Inc. logo

Alphatec Holdings, Inc.

ATEC

6.15 USD

Cue Health Inc. logo

Cue Health Inc.

HLTH

0.043 USD

NanoString Technologies, Inc. logo

NanoString Technologies, Inc.

NSTG

0.105 USD

Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc.

ORGO

2.85 USD

ImmunoGen, Inc. logo

ImmunoGen, Inc.

IMGN

31.235 USD

Alector, Inc. logo

Alector, Inc.

ALEC

5.64 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)